Brief: Akari Therapeutics Reports Second Quarter 2022 Financial Results And Highlights Recent Pipeline Progress

Akari Therapeutics

27/09/2022 14:36

Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PIPELINE PROGRESS
    * AKARI THERAPEUTICS - PHASE 3 PART A CLINICAL TRIAL OF IN
SEVERE
PEDIATRIC HSCT-TMA REMAINS ON TRACK FOR EXPECTED DATA READOUT IN
H1 OF 2023

Source text for Eikon:  ID:nGNX6wl4F4 
Further company coverage:  AKTX.O